iRhythm Technologies, Inc. (IRTC)
After hours:
| Previous Close | 109.85 |
| Open | 110.41 |
| Bid | 111.45 x 100 |
| Ask | 111.64 x 100 |
| Day's Range | 108.84 - 113.00 |
| 52 Week Range | 70.24 - 140.23 |
| Volume | |
| Avg. Volume | 449,259 |
| Market Cap | 3.47B |
| Beta (5Y Monthly) | 1.31 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.04 |
| Earnings Date | May 02, 2024 - May 06, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 139.11 |
ZacksiRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Simply Wall St.Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
We feel now is a pretty good time to analyse iRhythm Technologies, Inc.'s ( NASDAQ:IRTC ) business as it appears the...
GlobeNewswireiRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the closing of its offering of 1.50% Convertible Senior Notes due 2029 (the “notes”) for gross proceeds of $661.25 million in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities
